Route of delivery in women with stillbirth: Results from the stillbirth collaborative research network

Obstetrics and Gynecology

Volumn 129, Issue 4, 2017, Pages 693-698

  Boyle, Annelee ^a   Preslar, Jessica P ^a   Hogue, Carol J R ^a   Silver, Robert M ^a   Reddy, Uma M ^a   Goldenberg, Robert L ^a   Stoll, Barbara J ^a   Varner, Michael W ^a   Conway, Deborah L ^a   Saade, George R ^a   Bukowski, Radek ^a   Dudley, Donald J ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CESAREAN SECTION; DYSTOCIA; FEMALE; FETUS HEART; GESTATION PERIOD; HUMAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSTETRIC DELIVERY; PLACENTA PREVIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOLUTIO PLACENTAE; STILLBIRTH; UTERUS RUPTURE; DEMOGRAPHY; EPIDEMIOLOGY; PREGNANCY; PROCEDURES; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES; UTERINE RUPTURE;

ADULT; CESAREAN SECTION; DELIVERY, OBSTETRIC; DEMOGRAPHY; DYSTOCIA; FEMALE; HUMANS; LABOR, INDUCED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PREGNANCY; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS; STILLBIRTH; UNITED STATES; UTERINE RUPTURE;

EID: 85014679002     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000001935     Document Type: Article

References (24)

1. National Center for Health Statistics.Model state vital statistics act and regulations. 1992 revision. Hyattsville (MD): NCHS; 1994. Available at: http://www.cdc.gov/nchs/data/misc/mvsact92b.pdf. Retrieved December 7, 2015.
2. MacDorman MF, Reddy UM, Silver RM. Trends in stillbirth by gestational age in the US, 2006-2012. Obstet Gynecol 2015: 126;1146-50.
3. Management of stillbirth. ACOG Practice Bulletin No. 102. American College of Obstetricians and Gynecologists. Obstet Gynecol 2009;113:748-61.
4. Royal College of Obstetricians and Gynaecologists. Green-top guideline 55: late intrauterine fetal death and stillbirth. 2010. Available at: https://www.rcog.org.uk/globalassets/documents/guidelines/gtg-55.pdf. Retrieved December 7, 2015.
5. Dipple AL. Death of a fetus in utero. Bull Johns Hopkins Hosp 1934;54:24.
6. Wagaarachchi PT, Ashok PW, Narvekar NN, Smith NC, Templeton A. Medical management of late intrauterine death using a combination of mifepristone and misoprostol. BJOG 2002;109:443-7.
7. Nakintu N. A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour in women with intra uterine fetal death in Mulago Hospital, Uganda. Afr Health Sci 2001;1:55-9.
8. Neilson JP, Hickey M, Vazquez J. Medical treatment for early fetal death (less than 24 weeks). The Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD002253. DOI: 10.1002/14651858.CD002253.pub3.
9. Gómez Ponce de León R, Wing D, Fiala C. Misoprostol for intrauterine fetal death. Int J Gynaecol Obstet 2007;99:S190-3.
10. Nyende L, Towobola OA, Mabina MH. Comparison of vaginal and oral misoprostol, for the induction of labour in women with intra-uterine foetal death. East Afr Med J 2004;81:179-82.
11. Chittacharoen A, Herabutya Y, Punyavachira P. A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstet Gynecol 2003;101:70-3.
12. Cabrol D, Dubois C, Cronje H, Gonnet JM, Guillot M, Maria B, et al. Induction of labor with mifepristone (RU 486) in intrauterine fetal death. Am J Obstet Gynecol 1990;163:540-2.
13. Van Mensel K, Claerhout F, Debois P, Keirse MJ, Hanssens M. A randomized controlled trial of misoprostol and sulprostone to end pregnancy after fetal death. Obstet Gynecol Int 2009; 2009:496320.
14. Toaff R, Ayalon D, Gogol G. Clinical use of high concentration oxytocin drip. Obstet Gynecol 1971;37:112-20.
15. Winkler CL, Gray SE, Hauth JC, Owen J, Tucker JM. Midsecond-trimester labor induction: concentrated oxytocin compared with prostaglandin E2 vaginal suppositories. Obstet Gynecol 1991;77:297-300.
16. Dodd JM, Crowther CA. Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: a systematic review. Eur J Obstet Gynecol Reprod Biol 2006;125:3-8.
17. Jain JK,Mishell DR Jr. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy. N Engl J Med 1994;331:290-3.
18. Dickinson JE, Evans SF. The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination [published erratum appears in Am J Obstet Gynecol 2005;193:597]. Am J Obstet Gynecol 2002;186:470-4.
19. Tang OS, Lau WN, Chan CC, Ho PC. A prospective randomised comparison of sublingual and vaginal misoprostol in second trimester termination of pregnancy. BJOG 2004;111: 1001-5.
20. Di Stefano V, Santolaya-Forgas J, Faro R, Duzyi C, Oyelese Y. Mode of delivery in stillbirth, 1995-2004. Reprod Sci 2016;23: 92-7.
21. Goldenberg RL, Farrow VA, McClure EM, Reddy UM, Fretts RC, Schulkin J. Stillbirth: knowledge and practice among U.S. obstetrician-gynecologists. Am J Perinatol 2013;30:813-20.
22. Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirths. JAMA 2011;306:2459-68.
23. Parker CB, Hogue CJ, Koch MA, Willinger M, Reddy UM, Thorsten VR, et al. Stillbirth Collaborative Research Network: design, methods and recruitment experience. Paediatric Perinatal Epidemiol 2011;25:425-35.
24. Landon MB, Hauth JC, Leveno KJ, Spong CY, Leindecker S, Varner MW, et al. Maternal and perinatal outcomes associated with a trial of labor after prior cesarean delivery. N Engl J Med 2004;351:2581-9.